Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 948-071-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 January 2018 to 10 May 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF), Testing Guidelines for Toxicology Studies, 12 NouSan No. 8147, 24 November 2000
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- no
Test material
- Reference substance name:
- Reaction mass of C12-14 tert-alkylamines and dimethyl hydrogen phosphate and methyl dihydrogen phosphate
- EC Number:
- 948-071-5
- IUPAC Name:
- Reaction mass of C12-14 tert-alkylamines and dimethyl hydrogen phosphate and methyl dihydrogen phosphate
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- - Purity: >98% (nominal); This substance has a Unknown or Variable composition, is a Complex reaction product, or a Biological material (UVCB)
- Description: Yellow liquid
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS (UK) Limited, Oxon, UK
- Females (if applicable) nulliparous and non-pregnant: Yes
- Age at study initiation: 8 to 12 weeks of age
- Weight at study initiation: Ranged from 170 to 179 g
- Fasting period before study: Yes, overnight immediately before dosing
- Housing: Suspended solid floor polypropylene cages with stainless steel mesh lids and furnished with softwood flake bedding (Datesand LTD., Cheshire, UK).
- Diet (e.g. ad libitum): Free access to 2014C Teklad Global Certified Rodent diet supplied by Envigo RMS (UK) Limited, Oxon, UK
- Water (e.g. ad libitum): Free access to tap drinking water
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 19 to 25 °C
- Humidity: 30 to 70% respectively
- Air changes: At least fifteen changes per hour
- Photoperiod: 12 hours continuous light and 12 hours darkness
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- DMSO
- Details on oral exposure:
- - The test item was freshly prepared, as required, as a solution in dimethyl sulfoxide.
- Dimethyl sulfoxide was used as it produced the most suitable formulation at the required concentration.
- The test item was formulated with no correction for the test item purity within 2 hours of being applied to the test system. It was assumed that the formulation was stable for this duration.
- No analysis was conducted to determine the homogeneity, concentration or stability of the test item formulation. (This is an exception with regard to GLP and has been reflected in the GLP compliance statement within the study report). - Doses:
- 2000 and 300 mg/kg
- No. of animals per sex per dose:
- One animal per dose, followed by five animals per dose
- Control animals:
- no
- Details on study design:
- Using available information on the toxicity of the test item, 2000 mg/kg was chosen as the starting dose and a single animal was treated with this dose.
Due to mortality at a dose level of 2000 mg/kg, an additional animal was treated at a dose level of 300 mg/kg. In the absence of toxicity at a dose level of 300 mg/kg, an additional group of animals was treated at this dose level. A total of five animals were therefore treated at a dose level of 300 mg/kg in the study.
All animals were dosed once only by gavage, using a metal cannula attached to a graduated syringe. The volume administered to each animal was calculated according to the fasted body weight at the time of dosing. Treatment of animals was sequential. At least 24 hours was allowed between each dose group to confirm the survival of the previously dosed animals.
Clinical observations were made 30 minutes, 1, 2, and 4 hours after dosing and then daily for up to 14 days. Morbidity and mortality checks were made twice daily, early and late during normal working days, and once daily at weekends and public holidays.
Individual body weights were recorded on Day 0 (the day of dosing) and on Days 7 and 14 or at death.
At the end of the observation period the surviving animals were killed by cervical dislocation. All animals were subjected to gross necropsy. This consisted of an external examination and opening of the abdominal and thoracic cavities. The appearance of any macroscopic abnormalities was recorded. No tissues were retained.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 300 mg/kg bw
- Based on:
- test mat.
- Mortality:
- At the dose level of 2000 mg/kg, the (one) animal was found dead thirty minutes after dosing.
At the dose level of 300 mg/kg, there were no unscheduled deaths. - Clinical signs:
- At the dose level of 2000 mg/kg, no signs of systemic toxicity were noted during the observation period.
At the dose level of 300 mg/kg, hunched posture was noted in one animal during the day of dosing. No other signs of systemic toxicity were noted. - Body weight:
- Dose level of 2000 mg/kg - see tables section, below.
At the dose level of 300mg/kg, based on historical data from the supplier for this strain all animals showed expected gains in body weight over the observation period. - Gross pathology:
- At the dose level of 2000 mg/kg, abnormalities noted at necropsy were dark liver, dark kidneys and reddened gastric mucosa.
At the dose level of 300 mg/kg, no abnormalities were noted at necropsy.
Any other information on results incl. tables
Individual Necropsy Findings -2000 mg/kg
Dose Level |
Animal Number |
Time of Death |
Macroscopic Observations |
2000 |
1-0 Female |
Found dead 30 minutes after dosing |
Liver: Dark Kidneys: Dark Gastric Mucosa: Reddened
|
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The acute oral median lethal dose (LD50) of the test item in the female Wistar strain rat was estimated to be in the range of 300 to 2000 mg/kg body weight and classed as Category 4, according to GHS.
- Executive summary:
The study was performed to the standardized guideline OECD 420, under GLP conditions to assess the acute oral toxicity of the test item in the Wistar strain rat.
Following a sighting test at dose levels of 2000 mg/kg and 300 mg/kg body weight, an additional four fasted females was given a single oral dose of the test item, as a solution in dimethyl sulfoxide, at a dose level of 300 mg/kg body weight followed with a 14-day observation period. Clinical signs and body weight development were monitored during the study. All animals were subjected to gross necropsy.
The animal treated at a dose level of 2000 mg/kg was found dead thirty minutes after dosing and all animals dosed at 300 mg/kg survived to the scheduled sacrifices. Hunched posture was noted in one animal treated at a dose level of 300 mg/kg during the day of dosing. No other signs of systemic toxicity were noted. Based on historical data from the supplier for this strain, surviving animals showed expected gains in body weight over the observation period. Abnormalities noted at necropsy of the animal treated at a dose level of 2000 mg/kg that was found dead during the study were dark liver, dark kidneys and reddened gastric mucosa.
The acute oral median lethal dose (LD50) of the test item in the female Wistar strain rat was estimated to be in the range of 300 to 2000 mg/kg body weight and classed as Category 4, according to GHS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.